These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 9291751

  • 1. Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.
    Tong MJ, Lai LP, Murakami-Mori K.
    West J Med; 1997 Aug; 167(2):103-5. PubMed ID: 9291751
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. PSG consensus statement on management of hepatitis C virus infection--2003.
    Hamid S, Umar M, Alam A, Siddiqui A, Qureshi H, Butt J, Pakistan Society of Gastroenterology.
    J Pak Med Assoc; 2004 Mar; 54(3):146-50. PubMed ID: 15129876
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hepatitis C: diagnosis and treatment.
    Scotiniotis I, Brass CA, Malet PF.
    J Gen Intern Med; 1995 May; 10(5):273-82. PubMed ID: 7542329
    [No Abstract] [Full Text] [Related]

  • 7. The relationship between hepatocellular carcinoma and hepatitis B and C virus.
    Kohli A.
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):96-8. PubMed ID: 27057807
    [No Abstract] [Full Text] [Related]

  • 8. Case report: Occurrence of hepatocellular carcinoma 4.5 years after successful treatment with virus clearance for chronic hepatitis C.
    Miyano S, Togashi H, Shinzawa H, Sugahara K, Matsuo T, Takeda Y, Saito K, Saito T, Ishiyama S, Kaneko M, Takahashi T.
    J Gastroenterol Hepatol; 1999 Sep; 14(9):928-30. PubMed ID: 10535477
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Primary biliary cirrhosis exacerbated by a course of acute hepatitis C and subsequent interferon therapy.
    Yoshikawa M, Mimura M, Shiroi A, Kojima H, Fukui H, Sugimoto Y, Mochi T.
    Am J Gastroenterol; 2000 Sep; 95(9):2396-7. PubMed ID: 11007259
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sofosbuvir and ribavirin for treatment of compensated recurrent hepatitis C virus infection after liver transplantation.
    Charlton M, Gane E, Manns MP, Brown RS, Curry MP, Kwo PY, Fontana RJ, Gilroy R, Teperman L, Muir AJ, McHutchison JG, Symonds WT, Brainard D, Kirby B, Dvory-Sobol H, Denning J, Arterburn S, Samuel D, Forns X, Terrault NA.
    Gastroenterology; 2015 Jan; 148(1):108-17. PubMed ID: 25304641
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Varying incidence of cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis C responding differently to interferon therapy.
    Shindo M, Ken A, Okuno T.
    Cancer; 1999 May 01; 85(9):1943-50. PubMed ID: 10223234
    [Abstract] [Full Text] [Related]

  • 19. A patient with hepatitis C-related cirrhosis and hepatocellular carcinoma who was cured with an orthotopic liver transplantation and interferon therapy.
    Shibata M, Yanaga K, Morizane T, Yanagawa T, Hirakawa M, Ueno Y, Esquivel CO, Mitamura K.
    J Gastroenterol; 2003 May 01; 38(6):598-602. PubMed ID: 12858850
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.